Inhibition of histone deacetylases attenuates tumor progression and improves immunotherapy in breast cancer.

Lian, Bi; Chen, Xiaosong; Shen, Kunwei

Lian, Bi; Chen, Xiaosong; Shen, Kunwei.

Afiliación

Lian B; Department of General Surgery, Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Chen X; Department of General Surgery, Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Shen K; Department of General Surgery, Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Front Immunol ; 14: 1164514, 2023.

Article en En | MEDLINE | ID: mdl-36969235

Asunto(s)

Neoplasias de la Mama; Histona Desacetilasas; Humanos; Femenino; Histona Desacetilasas/metabolismo; Inhibidores de Histona Desacetilasas/efectos adversos; Neoplasias de la Mama/tratamiento farmacológico; Vorinostat; Inmunoterapia

Palabras clave

HDAC; breast cancer; immunotherapy; inhibitors; targets

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Histona Desacetilasas Límite: Female / Humans Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google